Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient stratification and treatment response prediction in neuropharmacotherapy using PET/MR
2014-001550-42Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of citalopram, duloxetine, venlafaxine, mirtazapine and escitalopram in major depressive disorder (MDD), sponsored by Medical University of Vienna. Primary endpoints: 5-HTT binding potential and occupancy, Resting-state brain activity and connectivity and 1 more. Started May 2014; status: completed.
02
Drugs
citalopramduloxetinevenlafaxinemirtazapineescitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2014-001550-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001550-42.